PTC Therapeutics Inc
XBER:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PTC Therapeutics Inc
XBER:BH3
|
US |
|
Husqvarna AB
F:HRZA
|
SE |
|
O
|
Orion Oyj
SWB:OFK
|
FI |
|
H
|
H&R Real Estate Investment Trust
OTC:HRUFF
|
CA |
Wall St Price Targets
BH3 Price Targets Summary
PTC Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for BH3 is 89.73 EUR with a low forecast of 61.94 EUR and a high forecast of 130.9 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is BH3's stock price target?
Price Target
89.73
EUR
According to Wall Street analysts, the average 1-year price target for BH3 is 89.73 EUR with a low forecast of 61.94 EUR and a high forecast of 130.9 EUR.
What is the Revenue forecast for PTC Therapeutics Inc?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 35%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for PTC Therapeutics Inc?
Projected CAGR
-4%
The compound annual growth rate for Operating Income over the next 8 years is -4%.
What is the Net Income forecast for PTC Therapeutics Inc?
Projected CAGR
-3%
Over the last 13 years, the compound annual growth rate for Net Income has been 70%. The projected CAGR for the next 8 years is -3%.
